2017 FDA Peptide Harvest

2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the FDA, with a total of 46. In turn, one of the highlights was the number of peptides (six) included in this list. Here, the six peptides are analyzed in terms of chemical structure, synthetic strategy us...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Musaimi, Othman, Al Shaer, Danah, de la Torre, Beatriz G., Albericio, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027222/
https://www.ncbi.nlm.nih.gov/pubmed/29735913
http://dx.doi.org/10.3390/ph11020042
_version_ 1783336561576771584
author Al Musaimi, Othman
Al Shaer, Danah
de la Torre, Beatriz G.
Albericio, Fernando
author_facet Al Musaimi, Othman
Al Shaer, Danah
de la Torre, Beatriz G.
Albericio, Fernando
author_sort Al Musaimi, Othman
collection PubMed
description 2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the FDA, with a total of 46. In turn, one of the highlights was the number of peptides (six) included in this list. Here, the six peptides are analyzed in terms of chemical structure, synthetic strategy used for their production, source, therapeutic use, and mode of action.
format Online
Article
Text
id pubmed-6027222
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60272222018-07-13 2017 FDA Peptide Harvest Al Musaimi, Othman Al Shaer, Danah de la Torre, Beatriz G. Albericio, Fernando Pharmaceuticals (Basel) Review 2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the FDA, with a total of 46. In turn, one of the highlights was the number of peptides (six) included in this list. Here, the six peptides are analyzed in terms of chemical structure, synthetic strategy used for their production, source, therapeutic use, and mode of action. MDPI 2018-05-07 /pmc/articles/PMC6027222/ /pubmed/29735913 http://dx.doi.org/10.3390/ph11020042 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Al Musaimi, Othman
Al Shaer, Danah
de la Torre, Beatriz G.
Albericio, Fernando
2017 FDA Peptide Harvest
title 2017 FDA Peptide Harvest
title_full 2017 FDA Peptide Harvest
title_fullStr 2017 FDA Peptide Harvest
title_full_unstemmed 2017 FDA Peptide Harvest
title_short 2017 FDA Peptide Harvest
title_sort 2017 fda peptide harvest
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027222/
https://www.ncbi.nlm.nih.gov/pubmed/29735913
http://dx.doi.org/10.3390/ph11020042
work_keys_str_mv AT almusaimiothman 2017fdapeptideharvest
AT alshaerdanah 2017fdapeptideharvest
AT delatorrebeatrizg 2017fdapeptideharvest
AT albericiofernando 2017fdapeptideharvest

Ejemplares similares